{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-056213","form_type":"8-K","ticker":"AVAH","cik":"0001832332","company_name":"Aveanna Healthcare Holdings, Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.555832+00:00","generated_at":"2026-06-02T06:57:16.431322+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aveanna Q1 revenue $490.7M (+5.2%), net loss narrows to $11.2M; raises FY2024 guidance","bullets":["Q1 revenue $490.7M (+5.2% YoY); gross margin $145.9M (29.7% of revenue).","Net loss improved to $11.2M from $32.0M; diluted EPS loss $(0.06) vs $(0.17).","Adjusted EBITDA $34.9M (+22.5% YoY), margin 7.1% vs 6.1%.","FY2024 revenue guidance raised to >$1,970M; adjusted EBITDA raised to >$150M.","Private Duty Services revenue +$22.1M; Home Health & Hospice revenue -$1.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-056213","json":"https://secwatch.observer/filing/0000950170-24-056213.json","markdown":"https://secwatch.observer/filing/0000950170-24-056213.md","text":"https://secwatch.observer/filing/0000950170-24-056213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832332/000095017024056213/0000950170-24-056213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832332/000095017024056213/avah-20240509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T06:57:16.431322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5087df4a27e921ff0b131a91b1cd667b8ec192ca","claim":"Aveanna Healthcare Holdings, Inc. reported three-month period ended March 30, 2024 results: revenue $490.7 million, net income Net loss was $11.2 million, EPS $(0.06) per diluted share. Guidance raised.","evidence_excerpt":"--- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year o Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 • First Quarter Net loss was $11.2 million, compared to net loss of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832332/000095017024056213/0000950170-24-056213-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three-month period ended March 30, 2024"},{"label":"Revenue","value":"$490.7 million"},{"label":"Net income","value":"Net loss was $11.2 million"},{"label":"EPS","value":"$(0.06) per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}